[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.173.253. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Special Communication
August 12/26, 2013

Promoting “Low T”A Medical Writer’s Perspective

Author Affiliations
  • 1Braun Medical Media, Amherst, Massachusetts
JAMA Intern Med. 2013;173(15):1458-1460. doi:10.1001/jamainternmed.2013.6892
Abstract

Despite progress in raising the level of transparency about funding, conflicts of interest, and ghostwriting, drug companies remain free to pursue subtle and, therefore, effective means of marketing. Continuing medical education programs and “consensus” panels continue to be funded by companies selling products directly tied to the messages being conveyed by the resulting “educational” materials. And patient education materials continue to be created that, while factually accurate, subtly shift attitudes by including only selected facts and/or omitting ideas that would undermine the funder’s preferred paradigm.

×